Navigation Links
Alexion Pharmaceuticals to Present Data on Soliris(R) (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting
Date:12/7/2007

CHESHIRE, Conn., Dec. 7 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that data relating to paroxysmal nocturnal hemoglobinuria (PNH), as well as to Soliris(R) (eculizumab), a treatment for patients with PNH, will be presented at the 2007 American Society of Hematology Meeting, December 8 - 11 in Atlanta.

The following abstracts will be presented in a poster session on red cell regulation and disorders of production on Monday, December 10, 2007. The session will open at 10:30 a.m. and poster presentations will be held from 5:00 to 7:00 p.m. for each abstract. Additional information can be accessed through the links provided below.

-- Poster # 897-III: "High Incidence of Progression to Chronic Renal

Insufficiency in Patients with Paroxysmal Nocturnal Hemoglobinuria

(PNH)" Dr. Peter Hillmen et al.

-- Location: Hall B3 and B4

-- http://www.abstracts2view.com/hem07/view.php?nu=HEM07L1_5416

-- Poster # 891-III: "Sustained Improvements in Transfusion

Requirements, Fatigue and Thrombosis with Eculizumab Treatment in

Paroxysmal Nocturnal Hemoglobinuria" Dr. Gerard Socie et al.

-- Location: Hall B3 and B4

-- http://www.abstracts2view.com/hem07/view.php?nu=HEM07L1_5204

-- Poster # 902-III: "Disease-Related Symptoms Reported across a Broad

Population of Patients with Paroxysmal Nocturnal Hemoglobinuria" Dr.

Gabrielle Meyers et al.

-- Location: H
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Alexion Pharmaceuticals Invites You to Participate in its Third Quarter 2007 Results Conference Call and Web Cast
2. Alexion to Present at Investor Conferences
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...despite similar weight loss , , MONDAY, ...rbohydrate diet such as the popular Atkins program...le lose pounds over the course of a year. , Bu...in long-term improvement in mood, according to a s...Medicine . , People on both diets consumed roug...
(Date:11/9/2009)...tCall/ - Hard To Treat Diseases (HTDS.PK) www.htd...$41 billion international healthcare company, is a...r, Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.,...begin a five-year, $1 billion China initiative wit... its investment in its China R&D facility, and...
(Date:11/9/2009)...d in April 2010, Provides First Responders with a ...dge, MA (Vocus) November 9, 2009 -- When Stefan Sc...nspected a suspected mass grave at Dasht-e-Leili ...of experts to help interpret the scene. He knew th...tep in securing evidence of a human rights violati...
(Date:11/9/2009).../ -- Actress Mariska Hargitay and the Joyful Hea...to raise awareness about the need for domestic vio...ilding healing and wellness kits for women in cris... to each of the estimated 600 women currently bein...iolence shelters. ,, "Our goal is to shine a li...
(Date:11/9/2009)...ting a commitment to providing long-term healthcar...ital display technology options, LG Electronics is... Grade LCD HDTVs this week at the Association of H...g and exposition (booth #1760). ,, On display i...g-Term Care LCD HDTVs bring a sense of home away f...
Breaking Medicine News(10 mins):Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5
...Compilation of Patient Education Videos Addresses ...tient Safety Goals, Hospital Compare and Institute... ORLANDO, Fla., Dec. 10 19th Annual National For...,availability of the GetWellNetwork Regulations Pa...
...- Live webcast of surgical procedure to be held Th... p.m. Eastern Time -, REDWOOD CITY, Calif., Dec. ... that leading cardiac surgeons from The Heart,Hosp...ort-access robotic CABG procedure using innovative...
..., ATLANTA Oregon Health & Science University Can...eated a way to identify proteins that are candidat...using an assay that yields results in just four da...ional assay, called RAPID, because it rapidly deli...
...SAFE digital identity and signature standard being...re organizations as secure method of confirming ...GO, Dec. 10 Aladdin Knowledge Systems,(Nasdaq: A...g authentication device is the first hardware prod...
..., A new study finds significant underuse of color...eneficiaries. The study, published in the January ...of the American Cancer Society, show that only 25 ... in both men and women in the United States. The A...
...- VELCADE, thalidomide and dexamethasone improved ... compared to thalidomide and ...m Pharmaceuticals,Inc. (Nasdaq: MLNM ) reported t...tudy compared VELCADE, thalidomide and,dexamethaso...
Other Medicine News:Health News:GetWellNetwork Offers Comprehensive Education Package Enabling Hospitals to Meet Compliance Requirements for Patient Education 2Health News:GetWellNetwork Offers Comprehensive Education Package Enabling Hospitals to Meet Compliance Requirements for Patient Education 3Health News:GetWellNetwork Offers Comprehensive Education Package Enabling Hospitals to Meet Compliance Requirements for Patient Education 4Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 2Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 3Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 4Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 5Health News:OHSU Cancer Institute researcher develops test for targeted therapy in acute myeloid leukemia 2Health News:Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association 2Health News:Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association 3Health News:Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association 4Health News:Many Medicare beneficiaries not receiving colorectal cancer screening 2Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 2Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 3Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 4Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 5Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 6
(Date:11/9/2009)...- Groundbreaking articles in current issues of J...explore, in depth, the emergence of cannabinoid me...nd its potential benefits for patients. ,, In t...authors, Sunil Aggarwal, PhD who is a member of th...nd who conducted the article,s research and Gregor...
(Date:11/9/2009)...e/ -- Asthmatx, Inc. presented the results of a se...d safety of bronchial thermoplasty delivered by th...ill impact allergy practices, this past weekend in...an College of Allergy, Asthma and Immunology (ACAA..."Where Could Bronchial Thermoplasty (BT) Fit Into ...
(Date:11/9/2009)... AMD LASERS just announced that industry leading d...the position of Medical Director. In his new role...earch and development of new soft and hard tissue ...uing education credits, authoring articles for rel...uring and seminar engagements. ,, "We are very ...
Breaking Medicine Technology:Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 3AMD LASERS Names Dr. James Jesse as Medical Director 2Relievant Medsystems Announces Completion of 2420 Million Financing 4689 1Relievant Medsystems Announces Completion of 2420 Million Financing 4689 2Relievant Medsystems Announces Completion of 2420 Million Financing 4689 3Parents Guide to Cord Blood Foundation Introduces New Brochure During Cord Blood Awareness Month to Address Critical Education Gap 50861 1Parents Guide to Cord Blood Foundation Introduces New Brochure During Cord Blood Awareness Month to Address Critical Education Gap 50861 2Parents Guide to Cord Blood Foundation Introduces New Brochure During Cord Blood Awareness Month to Address Critical Education Gap 50861 3Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 1Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 2Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 3Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 4Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 5
...LE PARK, N.C., Oct. 17 CeNeRx BioPharma,Inc., a c...ng innovative,treatments for diseases of the centr...tiated a Phase II clinical trial for its lead prod...r depressive disorder (MDD). Tyrima is,a selective...nown as RIMAs,or reversible inhibitors of monoamin...
...ty of Original Black Elderberry Products, Sambucol...ice the Antioxidants of Both,Blueberries and Cranb...own berry,Sambucus nigra L, otherwise known as bla...orthwest Africa and southwest Asia, is making itse...e form of a dietary supplement,called Sambucol(R),...
Other Medicine Technology:CeNeRx BioPharma Initiates Phase II Clinical Trial of Its Novel Antidepressant Agent Tyrima(TM) 2CeNeRx BioPharma Initiates Phase II Clinical Trial of Its Novel Antidepressant Agent Tyrima(TM) 3Just in Time for Winter, a New Berry That's Good for Your Health 2Just in Time for Winter, a New Berry That's Good for Your Health 3
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: